CONE-ROD DYSTROPHY
Clinical trials for CONE-ROD DYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new CONE-ROD DYSTROPHY trials appear
Sign up with your email to follow new studies for CONE-ROD DYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Stem cell injection trial aims to restore vision in the blind
Disease control Recruiting nowThis study is testing a new treatment called OpCT-001 for adults with inherited eye diseases that cause blindness, such as retinitis pigmentosa. The treatment involves injecting lab-grown light-sensitive eye cells into the back of the eye. The main goals are to see if the treatme…
Matched conditions: CONE-ROD DYSTROPHY
Phase: PHASE1, PHASE2 • Sponsor: BlueRock Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
First-Ever human test of gene therapy for rare, blinding eye disease begins
Disease control Recruiting nowThis is the first human trial of an experimental gene therapy called ACDN-01 for people with ABCA4-related eye diseases like Stargardt disease. The study will test the safety and early signs of effectiveness of a single injection into the eye. Fifteen adult participants will be f…
Matched conditions: CONE-ROD DYSTROPHY
Phase: PHASE1, PHASE2 • Sponsor: Ascidian Therapeutics, Inc • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Finding the right people for future vision trials
Knowledge-focused Recruiting nowThis study aims to identify people with specific inherited eye diseases, like Stargardt disease, who might be eligible for future treatment trials. It will recruit 50 participants to perform tests that check their genetic profile and eye health. The goal is to create a pool of pr…
Matched conditions: CONE-ROD DYSTROPHY
Sponsor: Ascidian Therapeutics, Inc • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:24 UTC